This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. Treating Insomnia With Cannabinoids.
While initial cases of the phenomenon were associated with consumption of cannabinoid oil products via the use of unregulated vapor cartridges , the CDC reports that some cases have also been linked to the use of nicotine only. Three people have died as a result of the illness, and a fourth death is under investigation. .”
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
The truth is that total count tests are not a good indicator of cannabis and hemp product safety for the following reasons: Pathogenic microbes may still be present Testing methods often do not agree Growers are discouraged from using beneficial microbes Growers are encouraged to use remediation. fumigatus, A.
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.
Oxford Cannabinoid Technologies Holdings plc. After confirmation of 6-months stability of tech-transfer batch, the work has been initiated, with preliminary data packages available by the second half of September, well within the proposed timelines. Pre-Close Trading Update; US OTC QB Market Application. &
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.
As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. and derived products containing cannabinoids, including CBD, as “Novel Food” under the EU Novel Food Catalogue. Read the entire article at The Fresh Toast.
Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Safety and Tolerability (S&T) was assessed by asking participants to record Adverse Events (AEs).
Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. The EFSA guidance on cannabinoids strongly echoes the U.S. The EFSA guidance on cannabinoids strongly echoes the U.S.
Luckily, states such as Colorado, Washington, and California have had marijuana laws in place long enough for researchers to collect data and better understand the effects of legalization on behaviors such as driving under the influence. Their results may assuage some of these concerns. FACTORS INFLUENCING RESULTS. INADEQUATE TESTING.
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.
They require a process in which THC or other cannabinoid particles are reduced to nanoscopic size that allows them to then be mixed with water or other aqueous liquids. There is not extensive safetydata available, however. The nanoemulsion method ALT uses is effective for all cannabinoids, not only THC, he said.
Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis.
Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Since then, numerous studies have explored cannabinoid activity in the different skin layers.
NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.
Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.
As safety and compliance testing regulations evolve, it will be important to include more than the standard As, Cd, Hg, and Pb to the list of regulated metals. Noncartridge heating methods of cannabis flower and concentrate were compared, and results indicate that the heating device itself is a source of metal contamination.
We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.
Charlotte’s Web took the unusual step of issuing a public response to the refusals, available here , with a link to the company’s also public letter to the FDA here , which responds directly to the agency’s criticisms of the data provided and alleging factual inaccuracies in its response. Still About Safety. Not About Enforcement.
Researchers at the University of Nottingham conducted a meta-analysis of previous studies, reports the Nottingham Post, concluding that cannabinoids could reduce the severity of stroke as well as improve neurological outcomes. The findings have identified the potential for cannabinoids to reduce brain damage caused by stroke. “The
Hexahydrocannabinol (HHC), which was patented in the late 1940s as a “therapeutic substance having marihuana activity,” is a cannabinoid that’s growing in popularity and availability. Hydrogenation of THC isomers such as delta-9-THC or delta-8-THC results in the formation of hexahydrocannabinol (HHC), a hydrogenated cannabinoid.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Seeks To Identify Novel Cannabinoids For Therapeutic Use. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safetydata will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. CHARLOTTE, N.C.–(BUSINESS
An example of these laboratories is Praxis Laboratory which was said to have provided falsified testing data for more than 1,200 cannabis products. Their statements also included something to likes of an employee stealing data and then contacting the regulators. Cannabinoids. Importance. THC, CBD , CBG , THCV , etc.
“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.
The research authors revealed that hemp seed cake, a by-product from hemp oil extraction, contained low cannabinoids, a healthy source of fiber, and crude protein for cattle and other animals. But regulators are unyielding, expressing skepticism that, if allowed, end consumers may risk exposure to unsafe levels of cannabinoid-laced meat.
The European Food Safety Authority (“ EFSA ”), the European equivalent of the U.S. Food and Drug Administration (“FDA”), recently changed guidance on cannabinoids, declaring that all new food products infused with the plant or its derivatives should receive a pre-market approval under the European Union “novel food” regulation.
Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).
Chemotypes : Types of cannabis that are grouped by their most abundant cannabinoid. Chemovars: Types of cannabis which are loosely defined and grouped, based on at least one or two of the most abundant cannabinoids and two-to-four main terpenes. 10% THC and 30% THC plants could both be Type I, as long as THC is the major cannabinoid).
CBD for Pets Yes the Data says it works ! It mainly consists of two types of cannabinoid receptors (CB1 and CB2). These receptors are built to interact with endocannabinoids (cannabinoids naturally produced by the brain). The endocannabinoid system is essentially the system that processes cannabinoids introduced into the body.
OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.
” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.
THC and CBD, along with their un-decarboxylated counterparts THC-A and CBD-A (as well as cannabis’s lesser known cannabinoids) all have medical benefits when applied topically, so opt for full spectrum, whole plant when possible. Sure a lot of the cannabinoids are gone, but there are still lots left. .
According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Use of Non-controlled Cannabinoids in Food.
The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety. www.igcinc.us
The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as directed by HB 3000 (2021). Delta-8 THC and other Artificially Derived Cannabinoids. Artificially Derived Cannabinoids Allowed in SOME Situations.
The approval, made through the European Commission Decision Reliance Procedure (ECDRP), is based on data from a positive Phase 3 safety and efficacy study evaluating 25 mg/kg/day of GW’s cannabidiol. The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.
The European Food Safety Authority (EFSA) has looked at THC levels in 12 different categories of hemp foods, including hemp oil, breads and teas. The January report from the European Food Safety Authority (EFSA) looked at THC levels in 12 different categories of hemp foods, including hemp oil, breads and teas. Davide Arcella . .
Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content